Press release
Pharmaceutical Quality Management Software Market to Reach $2.98 Billion by 2030
Pharmaceutical Quality Management Software (QMS) Market by Process (Clinical Trial, Regulatory, Manufacturing, Commercialization), Application (eSOP, CAPA, Compliance), Size (Large, Small), End User (pharma, biotech, CRO), Region - Global Forecast to 2030According to MarketsandMarkets Trademark , The global Pharmaceutical Quality Management Software (QMS) Market [https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-quality-management-software-market-79122728.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is experiencing rapid expansion as pharmaceutical and biotech companies prioritize quality, compliance, and operational efficiency across the product lifecycle. The market is projected to grow from USD 1.59 billion in 2025 to USD 2.98 billion by 2030, registering a strong CAGR of 13.3% during the forecast period.
With insights derived from 80 data tables and 50 figures across 250 pages, the report highlights key trends, growth drivers, and competitive strategies shaping the future of quality management in the pharmaceutical industry.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=79122728 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=79122728&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
What Is Driving Market Growth?
The pharmaceutical quality management software market is advancing rapidly due to increasing emphasis on end-to-end product lifecycle management.
Why is adoption accelerating? Pharmaceutical companies are under growing pressure to ensure quality from research and development through manufacturing and post-market surveillance. The globalization of manufacturing operations has created a strong need for standardized, digital quality systems across multiple locations.
How is technology reshaping quality management? Automation of critical workflows such as CAPA, audits, and change management is reducing human error and improving efficiency. At the same time, advanced analytics are enabling data-driven decision-making, helping organizations proactively identify risks and ensure compliance.
In addition, stricter regulatory scrutiny-particularly in emerging markets-along with the shift toward paperless operations and a strong focus on patient safety, are reinforcing the adoption of QMS platforms.
Which Enterprise Segment Leads the Market?
By enterprise size, large enterprises accounted for the largest share of the market in 2024.
What drives this dominance? Large pharmaceutical organizations operate complex, global manufacturing networks and face stringent regulatory requirements. Their ability to invest in advanced digital infrastructure allows them to deploy comprehensive QMS platforms that integrate multiple quality processes.
These companies prioritize robust systems to ensure product consistency, improve traceability, and minimize compliance risks. Their ongoing focus on digital transformation and automation further strengthens adoption within this segment.
Who Are the Primary End Users?
Pharmaceutical companies represent the largest end-user segment in the market.
Why do pharma companies lead adoption? Maintaining stringent quality standards across drug development, manufacturing, and distribution is critical in the pharmaceutical industry. Regulatory bodies impose strict compliance requirements, making advanced QMS solutions essential.
These systems streamline documentation, manage deviations, track compliance metrics, and support continuous improvement initiatives, ensuring consistent product quality and regulatory adherence.
Which Region Dominates the Market?
North America held the largest share of the pharmaceutical quality management software market in 2024.
What supports this leadership? The region's highly regulated pharmaceutical environment, coupled with complex and frequently updated guidelines from regulatory authorities, drives strong demand for advanced QMS solutions.
Significant investments in digital transformation, along with widespread adoption of cloud-based platforms and AI-enabled analytics, are further strengthening market growth. Pharmaceutical companies in the US and Canada are increasingly leveraging centralized quality systems to manage complex supply chains and decentralized manufacturing operations.
Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=79122728 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=79122728&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Competitive Landscape
Key players operating in the pharmaceutical quality management software market include Veeva Systems Inc., MasterControl Solutions, Inc., Honeywell International Inc., IQVIA, Qualio, Inc., Hexagon AB, AssurX, Inc., QT9 Software, Dassault Systemes, ComplianceQuest, Ideagen, SoftExpert, Instem, Intelex Technologies, Intellect, Inc., and AmpleLogic.
These companies are focusing on innovation, cloud-based solutions, and AI-driven capabilities to strengthen their market position and address evolving regulatory requirements.
Why This Matters for Industry Stakeholders
For pharmaceutical manufacturers, biotech firms, and CROs, the adoption of advanced QMS solutions is becoming a strategic necessity.
What should decision-makers prioritize? Investing in integrated, scalable, and cloud-enabled quality management systems will be critical to ensuring compliance, improving operational efficiency, and maintaining product quality across global operations.
As regulatory complexity increases and digital transformation accelerates, pharmaceutical quality management software will play a central role in enabling organizations to deliver safe, effective, and compliant products to market.
Related Reports:
Pharmaceutical Manufacturing Software Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=259341162&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030
Pharmaceutical Packaging Equipment Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pharmaceutical-quality-management-software-market-to-reach-298-billion-by-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Quality Management Software Market to Reach $2.98 Billion by 2030 here
News-ID: 4447054 • Views: …
More Releases from ABNewswire
Delicate Software Solutions Launches Integrated Mobile Attendance and WPS Payrol …
Image: https://www.abnewswire.com/upload/2026/05/f3b64242a299bb3561ef0466eda58eda.jpg
DUBAI, UAE - Delicate Software Solutions, a premier provider of enterprise automation tools in the Middle East, today announced the official launch of its next-generation Integrated Mobile App Attendance System. This innovative solution is designed to work in seamless tandem with their comprehensive HR and Payroll Software [https://www.delicatesoft.com/hr-payroll-software.html], specifically engineered to simplify Wages Protection System (WPS) compliance and workforce management for small and medium-sized enterprises across the United Arab…
New Report Highlights How Ready Logistics Infrastructure Reduces Operational Del …
In logistics, speed is no longer a competitive advantage - it's an expectation. Businesses expanding into new markets or scaling operations often face the same bottleneck: infrastructure. Construction, approvals, and setting up of facilities can sometimes get in the way of your best laid plans. The growing pressure on organisations to deliver faster has created a new game-changer in logistics and industrial property - the ready-to-use logistics park.
Immediate operational readiness
Ready-to-use…
How Excedify Quietly Redefined GD&T Training and Took the Market with It
Excedify, a relatively new entrant in the GD&T training market, has rapidly gained industry attention by shifting the focus from theoretical instruction to practical application. By introducing a structured 4-level learning pathway and integrating tools like a GD&T symbol generator and a browser-based 2D drawing environment, the company has addressed long-standing gaps in traditional training
For decades, the market for GD&T (Geometric Dimensioning and Tolerancing [https://www.excedify.com/bundles/gdt-certification-pathway]) training followed a predictable pattern.…
Excedify Partners with Michael A. Anleitner to Launch Advanced FMEA Online Train …
Excedify has partnered with Michael A. Anleitner, author of The Power of Deduction: Failure Modes & Effects Analysis for Design (2nd Edition), to develop a modern FMEA online training course. The program is based on the AIAG-VDA 7-step method and focuses on practical application, replacing outdated RPN-only approaches with structured Action Priority (AP) analysis.
Germany - May 4, 2026 - Excedify has announced a strategic partnership with Michael A. Anleitner, author…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
